‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease

Global NewsWednesday, October 29, 2025 at 5:56:10 PM
PositiveHealth
‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease
Health Canada has made a significant move by approving lecanemab, the first drug aimed at slowing the progression of Alzheimer's disease. This approval is crucial as it brings hope to many patients and families affected by this debilitating condition. With lecanemab already available in countries like the U.S., U.K., Japan, Mexico, and China, its introduction in Canada marks an important step in the global fight against Alzheimer's, potentially improving the quality of life for countless individuals.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Canada is likely to lose its measles elimination status. The U.S. could be next.
NegativeHealth
Canada is facing the possibility of losing its measles elimination status due to a persistent outbreak that has been ongoing for a year. This situation is concerning not just for Canada but also for the U.S., which could be next in line if vaccination rates do not improve. The implications of losing this status could lead to increased health risks and a resurgence of measles, a disease that was previously under control.
Weight loss drugs are bringing down the country's obesity rate, a survey shows
PositiveHealth
Recent findings from the Gallup National Health and Well-Being Index reveal that GLP-1 weight loss drugs are making a significant impact on the U.S. obesity rate, which has decreased from 39.9% to 37%. This is encouraging news as it suggests that medical advancements in weight management are helping to combat obesity, a major public health concern. The decline in obesity rates could lead to improved overall health outcomes for many Americans, making this a noteworthy development in the fight against obesity.
What is Mpox and why are cases rising in Europe?
PositiveHealth
Health officials in the UK are urging gay, bisexual, and other men who have sex with men to get vaccinated against Mpox as cases rise in Europe. This proactive approach is crucial in controlling the spread of the virus and protecting vulnerable communities. By encouraging vaccination, health authorities aim to reduce transmission rates and safeguard public health, highlighting the importance of awareness and preventive measures.
Latest from Health
Georgia Democrat Jon Ossoff gambles on shutdown to save health subsidies as reelection bid looms
NeutralHealth
Georgia Democrat Jon Ossoff is facing a critical moment as the federal government shutdown looms, which could significantly impact his reelection campaign. With health subsidies on the line, Ossoff's gamble to navigate this situation highlights the stakes for both him and his constituents. This situation matters because it not only affects Ossoff's political future but also the health and well-being of many Georgians who rely on these subsidies.
Obamacare Prices Become Public, Highlighting Big Increases
NegativeHealth
The recent release of Obamacare prices has revealed significant increases, raising concerns among consumers and policymakers alike. This matters because higher healthcare costs can lead to reduced access for many individuals, particularly those with lower incomes, and may spark debates about the future of healthcare reform in the United States.
Study finds EVs quickly overcome their energy-intensive build to be cleaner than gas cars
PositiveHealth
A recent study reveals that while electric vehicles (EVs) and their batteries require significant energy to produce, they quickly offset this initial environmental impact. Within just two years of use, EVs generate fewer overall emissions compared to traditional gas-powered cars. This finding is crucial as it highlights the long-term benefits of transitioning to electric vehicles, reinforcing their role in combating climate change and promoting cleaner air.
‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease
PositiveHealth
Health Canada has made a significant move by approving lecanemab, the first drug aimed at slowing the progression of Alzheimer's disease. This approval is crucial as it brings hope to many patients and families affected by this debilitating condition. With lecanemab already available in countries like the U.S., U.K., Japan, Mexico, and China, its introduction in Canada marks an important step in the global fight against Alzheimer's, potentially improving the quality of life for countless individuals.
Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
NeutralHealth
UnitedHealth and CVS are making strategic adjustments to their Medicare Advantage businesses, focusing on profitability rather than sheer size. This shift reflects a broader trend in the healthcare industry where companies are prioritizing financial health over expansion. It matters because these changes could impact the availability and quality of Medicare Advantage plans for consumers, potentially reshaping the landscape of healthcare options for seniors.
Teens who use weed before age 15 have more trouble later, a study finds
NegativeHealth
A recent study published in JAMA Network Open reveals that teens who start using cannabis before the age of 15 face greater challenges later in life. These young users are more likely to become frequent users and seek medical care for various health issues. This research highlights the importance of addressing early cannabis use, as it can lead to long-term consequences for adolescents' health and well-being.